Concepedia
Statistics
Publications
34
Citations
1.6K
H-Index
23
Active since
2014
Affiliations
University of Colorado Denver(Current)
The Ohio State University
The University of Texas MD Anderson Cancer Center
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
City of Hope
Bradley M. Haverkos is an author at University of Colorado Denver specializing in oncology, medicine, and hematology.
Publications per year
2014–2023
PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
Bradley M. Haverkos, Diana Abbott, Mehdi Hamadani et al. · Blood · 2017 · 242 citations · Full text
Medicine, Hematology, Oncology +17
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Steven M. Horwitz, Stephen M. Ansell, Weiyun Z. Ai et al. · Journal of the National Comprehensive Cancer Network · 2022 · 167 citations · Full text
Medicine, Oncology, Pathology +15
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
Neha Mehta–Shah, Stephen M. Ansell, Weiyun Z. Ai et al. · Journal of the National Comprehensive Cancer Network · 2020 · 118 citations · Full text
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018
Steven M. Horwitz, Stephen M. Ansell, Weiyun Z. Ai et al. · Journal of the National Comprehensive Cancer Network · 2018 · 78 citations · Full text
Life Sciences, Immunology, Oncology +11
Investigational cancer drugs targeting cell metabolism in clinical development
Douglas W. Sborov, Bradley M. Haverkos, Pamela Jo Harris · Expert Opinion on Investigational Drugs · 2014 · 72 citations
Medicine, Oncology, Pharmacology +17
1–5 of 34